CLEC12A-eiwit (N-His, mens)

CLEC12A

CD371, CLL-1, CLL1, DCAL-2, DCAL2, MICL

N-His

< 1.0 EU per μg protein as determined by the LAL method.

1.Flow cytometric analysis of anti-CLEC12A CAR expression. 5e5 of anti-CLEC12A CAR-293 cells were stained with 100 μL of 5 μg/mL of AF 488-conjugated human CLEC12A Protein (Site-Specific AF 488 Conjugation, His Tag, Cat. No. 11896-H85H-SD) and negative control protein. Non-transduced 293 cells were used as a control (left) . AF 488 signal was used to evaluate the binding activity (QC tested) . 2.Binding activity of AF 488-conjugated CLEC12A protein to PBMC cells. PBMC cells were stained with PE conjugated anti-CD3 antibody and AF 488-conjugated human CLEC12A Protein (Site-Specific AF 488 Conjugation, His Tag, Cat. No. 11896-H85H-SD) and detected by flow cytometry. PE signal was used to evaluate the content of CD3+ T cells in PBMCs. AF 488 signal was used to evaluate the non-specific binding activity to PBMCs (QC tested) .

His 75-Ala 275

The protein has a predicted molecular mass of 27.1 kDa.

Human